Cloretazine (VNP40101M) With Hematopoietic Cell Transplantation for Hematologic Malignancies

This study has been completed.
Sponsor:
Collaborator:
Vion Pharmaceuticals
Information provided by (Responsible Party):
M.D. Anderson Cancer Center
ClinicalTrials.gov Identifier:
NCT00521859
First received: August 27, 2007
Last updated: July 27, 2012
Last verified: July 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2010
  Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)